Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,613 | -5,738 | -3,339 | -25,231 | -20,668 |
| Depreciation Amortization | 252 | 169 | 83 | 388 | 279 |
| Accounts payable and accrued liabilities | -1,080 | -1,033 | -1,018 | -270 | -682 |
| Other Working Capital | -2,324 | -2,231 | -1,771 | -276 | -678 |
| Other Operating Activity | 2,864 | 1,998 | 1,435 | 1,870 | 2,034 |
| Operating Cash Flow | $-8,901 | $-6,835 | $-4,610 | $-23,519 | $-19,715 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -1 | -1 | -131 | -122 |
| Investing Cash Flow | $-3 | $-1 | $-1 | $-131 | $-122 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,605 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $4,605 | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 11,379 | 11,379 | 11,379 | 35,029 | 35,029 |
| End Cash Position | 7,080 | 4,543 | 6,768 | 11,379 | 15,192 |
| Net Cash Flow | $-4,299 | $-6,836 | $-4,611 | $-23,650 | $-19,837 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,901 | -6,835 | -4,610 | -23,519 | -19,715 |
| Capital Expenditure | -3 | -1 | -1 | -132 | -123 |
| Free Cash Flow | -8,904 | -6,836 | -4,611 | -23,651 | -19,838 |